Global SPECT Radiopharmaceuticals Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global SPECT Radiopharmaceuticals Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
A Single Photon Emission Computed Tomography (SPECT) scan is a type of nuclear imaging test that shows how blood flows to tissues and organs. Nuclear imaging requires small amounts of radioactive materials called radiopharmaceuticals – injected, inhaled or swallowed – to diagnose disease. SPECT radiopharmaceuticals include Tc-99m, Tl-201, Ga-67, I-123, In-111,and other SPECT isotopes.
SPECT Radiopharmaceuticals report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global SPECT Radiopharmaceuticals market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Oncology and Cardiology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for SPECT Radiopharmaceuticals industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, SPECT Radiopharmaceuticals key manufacturers include GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Eczacibasi-Monrol Nuclear Products, IBA Molecular Imaging and Jubilant Life Sciences, etc. GE Healthcare, Cardinal Health, Lantheus Medical Imaging are top 3 players and held % sales share in total in 2022.
SPECT Radiopharmaceuticals can be divided into Technetium-99, Thallium-201, Gallium-67 and Iodine-123, etc. Technetium-99 is the mainstream product in the market, accounting for % sales share globally in 2022.
SPECT Radiopharmaceuticals is widely used in various fields, such as Oncology, Cardiology and Thyroid,, etc. Oncology provides greatest supports to the SPECT Radiopharmaceuticals industry development. In 2022, global % sales of SPECT Radiopharmaceuticals went into Oncology filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global SPECT Radiopharmaceuticals market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
GE Healthcare
Cardinal Health
Lantheus Medical Imaging
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
IBA Molecular Imaging
Jubilant Life Sciences
Segment by Type
Technetium-99
Thallium-201
Gallium-67
Iodine-123
Indium-111
Other
Oncology
Cardiology
Thyroid
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the SPECT Radiopharmaceuticals market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of SPECT Radiopharmaceuticals, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the SPECT Radiopharmaceuticals industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of SPECT Radiopharmaceuticals in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, SPECT Radiopharmaceuticals introduction, etc. SPECT Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of SPECT Radiopharmaceuticals market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
SPECT Radiopharmaceuticals report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global SPECT Radiopharmaceuticals market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Oncology and Cardiology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for SPECT Radiopharmaceuticals industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, SPECT Radiopharmaceuticals key manufacturers include GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Eczacibasi-Monrol Nuclear Products, IBA Molecular Imaging and Jubilant Life Sciences, etc. GE Healthcare, Cardinal Health, Lantheus Medical Imaging are top 3 players and held % sales share in total in 2022.
SPECT Radiopharmaceuticals can be divided into Technetium-99, Thallium-201, Gallium-67 and Iodine-123, etc. Technetium-99 is the mainstream product in the market, accounting for % sales share globally in 2022.
SPECT Radiopharmaceuticals is widely used in various fields, such as Oncology, Cardiology and Thyroid,, etc. Oncology provides greatest supports to the SPECT Radiopharmaceuticals industry development. In 2022, global % sales of SPECT Radiopharmaceuticals went into Oncology filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global SPECT Radiopharmaceuticals market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
GE Healthcare
Cardinal Health
Lantheus Medical Imaging
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
IBA Molecular Imaging
Jubilant Life Sciences
Segment by Type
Technetium-99
Thallium-201
Gallium-67
Iodine-123
Indium-111
Other
Segment by Application
Oncology
Cardiology
Thyroid
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the SPECT Radiopharmaceuticals market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of SPECT Radiopharmaceuticals, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the SPECT Radiopharmaceuticals industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of SPECT Radiopharmaceuticals in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, SPECT Radiopharmaceuticals introduction, etc. SPECT Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of SPECT Radiopharmaceuticals market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.